Viva Biotech Holdings (HKG: 1873)
0.600
-0.020 (-3.23%)
Sep 10, 2024, 3:59 PM HKT
Viva Biotech Holdings Revenue
Viva Biotech Holdings had revenue of 981.82M CNY in the half year ending June 30, 2024, a decrease of -11.45%. This brings the company's revenue in the last twelve months to 2.00B, down -17.32% year-over-year. In the year 2023, Viva Biotech Holdings had annual revenue of 2.16B, down -9.42%.
Revenue (ttm)
2.00B CNY
Revenue Growth
-17.32%
P/S Ratio
0.57
Revenue / Employee
960.62K CNY
Employees
2,077
Market Cap
1.29B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionViva Biotech Holdings News
- 12 days ago - Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms - PRNewsWire
- 5 months ago - Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future - PRNewsWire
- 10 months ago - Viva Biotech Secures Approximately US$ 210 Million Funding - PRNewsWire
- 1 year ago - Viva Biotech (1873.HK) Announces 2023 Interim Results: Solid Growth in Main Business, Significant Rebound in Profitability - PRNewsWire
- 1 year ago - Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs - PRNewsWire
- 1 year ago - Viva Biotech's Portfolio Company DTx Pharma Reached the Acquisition Agreement with Novartis - PRNewsWire
- 1 year ago - Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million - PRNewsWire
- 1 year ago - Viva Biotech's Recent Conferences & Events Review - PRNewsWire